
What Biden’s Drug Price Negotiations Mean for You
Ten medications, costing tens of billions of dollars, will be the first to be subject to Medicare price negotiations
Arthur Allen is a senior correspondent at KFF Health News.
Ten medications, costing tens of billions of dollars, will be the first to be subject to Medicare price negotiations
Many generic drugs for cancer and ADHD, blood thinners and antibiotics are in short supply, in part because there is little profit in making them
Trials of all three vaccines came up with different efficacy numbers, but all offer crucial protection in this health emergency
Much of the pioneering work on mRNA vaccines was done with government money, though drugmakers could walk away with big profits
The test was halted when a participant suffered spinal cord damage, and U.S. scientists launched an investigation
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account